Keytruda News

6 Sept 20263:07 am

Health6 Sept 2026 · 3:07 am3:07 am

Cipla Partners with China's Qilu for US Launch of Merck's Keytruda Biosimilar

Cipla's US unit has partnered with China's Qilu Pharmaceutical to license QL2107, a biosimilar of Merck's cancer drug Keytruda, for commercialization in the US,

20 Aug 202612:22 pm

Biotechnology20 Aug 2026 · 12:22 pm12:22 pm

Create visual

Moderna, Merck Breakthrough Cancer Vaccine Shows Promise for Melanoma

A personalized cancer vaccine developed by Merck and Moderna shows promise for melanoma patients, significantly reducing cancer recurrence when combined with Ke

19 Aug 202611:01 pm

finance19 Aug 2026 · 11:01 pm11:01 pm

Create visual

Moderna stock surges 120% after cancer vaccine trial success with Merck's Keytruda

Moderna's stock surged by 120% following positive Phase 3 trial results for its mRNA cancer vaccine when combined with Merck's Keytruda, offering new hope for m

19 Aug 20269:30 pm

Science19 Aug 2026 · 9:30 pm9:30 pm

Create visual

Moderna and Merck's mRNA Cancer Vaccine Shows Promising Results for Melanoma

Moderna and Merck have reported promising results from a late-stage trial combining Moderna's mRNA therapy, intismeran, with Merck's Keytruda for melanoma patie

Keytruda News

#Keytruda

Cipla Partners with China's Qilu for US Launch of Merck's Keytruda Biosimilar

Moderna, Merck Breakthrough Cancer Vaccine Shows Promise for Melanoma

Moderna stock surges 120% after cancer vaccine trial success with Merck's Keytruda

Moderna and Merck's mRNA Cancer Vaccine Shows Promising Results for Melanoma

Discover Faster

Stay Organized

Create Effortlessly

Newsroom FAQs

Drive Greater Impact